NextBio Life Science Search Engine Advances Systems Biology Approach
to Research
Human Disease-Associated Mutation and Mouse Knockout Data Now Part of
Rich Collection of Gene Expression Studies Available for Search
CUPERTINO, Calif. (Business Wire EON/PRWEB ) June 9, 2008 --
NextBio’s life science search engine
significantly advances the systems biology approach to R&D and drug
discovery, says NextBio co-founder Ilya Kupershmidt, who will discuss
the innovative research tool at the Beyond Genome Conference this week.
He will also update the life science community on the latest additions
to NextBio’s content base, including new human
disease mutation and mouse knockout data sets. NextBio is the leading
life sciences search engine and enterprise Software-as-a-Service (SaaS)
solution being used by thousands of researchers every day and the world’s
leading pharmaceutical and biotech companies. The Beyond Genome
conference is being held in San Francisco from June 8 –
11.
"We recently reached another milestone in the development of the NextBio
life science search engine by integrating human disease-associated
mutation and mouse knockout data with the rich collection of gene
expression studies already available to users,”
stated Mr. Kupershmidt, Vice President of Product Management at NextBio. “The
new types of measurements add another dimension to NextBio’s
life science search engine by providing common human gene mutations and
mouse gene knockouts associated with cancer, and neurological and
metabolic disorders, amongst others."
On Tuesday, June 10 at 3:35 pm, Mr. Kupershmidt will present the latest
innovations of the NextBio life science search engine, including several
different search strategies of use to both commercial and academic
researchers and new content. Among the new features to be presented:
easily searchable clinical trial information, expanded experimental data
sets, enhanced literature search, advanced query capabilities, added
enterprise security and new APIs.
NextBio recently announced the public launch of the free version of its
life science search engine, enabling any researcher or clinician to
search the world’s public life sciences data
and literature. Moreover, by becoming a registered user of NextBio,
researchers can import their own experimental data into the NextBio
search engine, share it with the community and collaborate with others. “Our
goal at NextBio is to support and advance the vision of Open Biology,”
said Mr. Kupershmidt, “by letting scientists
around the globe easily share information and collaborate as never
before.”
NextBio is a sponsor and presenter at the Beyond Genome conference, and
representatives from the company will be available from June 8-11 to
discuss the NextBio life science search engine and its applications as
an essential tool for every life sciences researcher and clinician.
NextBio will also be hosting an on-line presentation of NextBio and its
capabilities on Friday, June 13, at 11 am PDT. This presentation will
cover applications of NextBio across diverse research settings both
within academic and commercial organizations.
More information on the “Beyond Genome”
conference and NextBio Webinar can be found at http://www.nextbio.com/b/corp/events.nb.
About NextBio
NextBio is a privately held, venture-backed company that provides an
innovative search engine specifically for the life science community.
NextBio provides instant access and search, user-generated content and
collaboration to scientists and clinicians worldwide, enabling them to
access and understand the world’s life
sciences information to find important new correlations, make
discoveries, and generate hypotheses as never before. NextBio is
implemented via a Software-as-a-Service (SaaS) model that enables users
to search directly or via internal company sites through the NextBio
Application Programming Interface (API). The enterprise version of the
NextBio search engine is being used in life science R&D and drug
development by researchers and clinicians at Johnson & Johnson
Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli
Lilly and Company, and Regeneron Pharmaceuticals, among others. For more
information on the company, please visit our website at http://www.nextbio.com.
See the original story at: http://eon.businesswire.com/releases/nextbio/search/prweb1009354.htm
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1TdW1tLUluc2UtSW5zZS1Qcm9mLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
